ouabain has been researched along with Cardiac Output, Low in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agalakova, NI; Bagrov, AY; Fedorova, OV; Lakatta, EG; Talan, MI | 1 |
| Böhm, M; Eissner, HJ; Kreuzer, E; Müller-Ehmsen, J; Reichart, B; Schmidt, U; Schwinger, RH; Stäblein, A; Uberfuhr, P; Uhlmann, R | 1 |
| Bavendiek, U; Brixius, K; Müller-Ehmsen, J; Münch, G; Schwinger, RH; Zobel, C | 1 |
| Hageman, KS; Musch, TI; Pickar, JG; Wolfram, S | 1 |
| Fujita, A; Hosono, M; Nakamura, K; Takahira, T | 1 |
| Mende, U; Meyer, W; Neumann, J; Nose, M; Schmitz, W; Scholz, H; Starbatty, J; Stein, B; von der Leyen, H; Wenzlaff, H | 1 |
| Joubert, PH | 1 |
1 review(s) available for ouabain and Cardiac Output, Low
| Article | Year |
|---|---|
Are all cardiac glycosides pharmacodynamically similar?
Topics: Animals; Cardiac Output, Low; Digitalis Glycosides; Digitoxin; Digoxin; Dose-Response Relationship, Drug; Heart Rate; Humans; Muscle Contraction; Ouabain | 1990 |
6 other study(ies) available for ouabain and Cardiac Output, Low
| Article | Year |
|---|---|
Coordinated shifts in Na/K-ATPase isoforms and their endogenous ligands during cardiac hypertrophy and failure in NaCl-sensitive hypertension.
Topics: Animals; Bufanolides; Cardiac Output, Low; Cardiomegaly; Enzyme Inhibitors; Hypertension; Isoenzymes; Ligands; Male; Ouabain; Rats; Rats, Inbred Dahl; Sodium Chloride; Sodium-Potassium-Exchanging ATPase | 2004 |
Effect of inotropic stimulation on the negative force-frequency relationship in the failing human heart.
Topics: Adult; Azetidines; Calcium; Cardiac Output, Low; Cardiotonic Agents; Cyclic AMP; Electric Stimulation; Female; Heart; Humans; Isometric Contraction; Isoproterenol; Male; Middle Aged; Myocardial Contraction; Ouabain | 1993 |
Effect of inotropic interventions on the force-frequency relation in the human heart.
Topics: Adrenergic beta-Agonists; Azetidines; Biomechanical Phenomena; Cardiac Output, Low; Cardiotonic Agents; Cyclic AMP; Drug Evaluation, Preclinical; Heart Rate; Humans; In Vitro Techniques; Isoproterenol; Myocardial Contraction; Ouabain; Papillary Muscles | 1998 |
Skeletal muscle ouabain binding sites are reduced in rats with chronic heart failure.
Topics: Animals; Binding Sites; Cardiac Output, Low; Chronic Disease; Fatigue; Female; Motor Activity; Muscle Fibers, Fast-Twitch; Muscle Fibers, Slow-Twitch; Muscle, Skeletal; Osmolar Concentration; Ouabain; Oxygen Consumption; Physical Endurance; Rats; Rats, Wistar; Severity of Illness Index; Time Factors; Ventricular Dysfunction, Left | 2002 |
Improvement of drug-induced cardiac failure by NKH477, a novel forskolin derivative, in the dog heart-lung preparation.
Topics: Animals; Blood Pressure; Cardiac Output, Low; Colforsin; Dogs; Drug Therapy, Combination; Female; Heart Rate; Male; Ouabain | 1992 |
Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Aged; Benzimidazoles; Calcium; Cardiac Output, Low; Cardiotonic Agents; Cyclic AMP; Female; Heart; Humans; Imidazoles; In Vitro Techniques; Isoenzymes; Male; Middle Aged; Myocardial Contraction; Myocardium; Ouabain; Oxindoles; Phosphodiesterase Inhibitors; Piperazines; Pyridazines; Pyridones | 1991 |